Monocarboxylate Transporter‐1 Is Dispensable for Hepatocellular Carcinoma Development
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | Shaimaa A. Gad, Bryan Bridgeman, Kyle Boedeker, Xianzhong Ding, Wei Qiu |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2025
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
DSN1 Interaction With Centromere‐Associated Proteins Promotes Chromosomal Instability in Hepatocellular Carcinoma
por: Hongrui Zhou, et al.
Publicado: (2024)
por: Hongrui Zhou, et al.
Publicado: (2024)
Levels of Bile Acid Metabolism Are Associated With Alterations of Gut Microbes in Hepatocellular Carcinoma
por: Zhihao Yang, et al.
Publicado: (2024)
por: Zhihao Yang, et al.
Publicado: (2024)
CYP4F11, an NRF2 Target Gene, Promotes Hepatocellular Carcinoma Cell Growth
por: Jinjing Chen, et al.
Publicado: (2025)
por: Jinjing Chen, et al.
Publicado: (2025)
CAF Specific Expression of Podoplanin May Be Dispensable for the Malignancy of Malignant Melanoma
por: Saskia Tauch, et al.
Publicado: (2024)
por: Saskia Tauch, et al.
Publicado: (2024)
VPS45 Contributes to the Progression of Hepatocellular Carcinoma by Triggering the Wnt/β‐Catenin Signaling Pathway
por: Renhou Zhi, et al.
Publicado: (2025)
por: Renhou Zhi, et al.
Publicado: (2025)
High‐Fat Diet Promotes Glycolysis in Hepatocellular Carcinoma by Suppressing Hepatic Kisspeptin Signaling in Mice
por: Rongqian Zhao, et al.
Publicado: (2025)
por: Rongqian Zhao, et al.
Publicado: (2025)
MFSD2A Overexpression Inhibits Hepatocellular Carcinoma Through TGF‐β/Smad Signaling
por: Chaowen Xiao, et al.
Publicado: (2025)
por: Chaowen Xiao, et al.
Publicado: (2025)
Whole‐Genome Bisulfite Sequencing Identifies Blood‐Based DNA Methylation Biomarker for Hepatocellular Carcinoma
por: Junsheng Zhao, et al.
Publicado: (2026)
por: Junsheng Zhao, et al.
Publicado: (2026)
Potential Influence of TNFSF15 Genetic Variants and Expression Levels on Disease Progression in Patients With Hepatocellular Carcinoma
por: Kuan‐Chun Hsueh, et al.
Publicado: (2025)
por: Kuan‐Chun Hsueh, et al.
Publicado: (2025)
The 5‐Methylcytosine RNA Modification in Hepatitis B Virus‐Negative Hepatocellular Carcinoma: Insights From Long‐Read Nanopore Sequencing
por: Tianhan Sun, et al.
Publicado: (2026)
por: Tianhan Sun, et al.
Publicado: (2026)
LncRNA FGD5‐AS1 Facilitates Hepatocellular Carcinoma Cell Stemness by Enhancing PKD1 mRNA Stability Through Binding With MSI2
por: Chenkun He, et al.
Publicado: (2025)
por: Chenkun He, et al.
Publicado: (2025)
Delta‐Like Homolog 2 Facilitates Malignancy of Hepatocellular Carcinoma via Activating EGFR/PKM2 Signaling Pathway
por: Xiangye Liu, et al.
Publicado: (2024)
por: Xiangye Liu, et al.
Publicado: (2024)
Downregulation of SLC7A11 by Bis(4‐Hydroxy‐3,5‐Dimethylphenyl) Sulfone Induces Ferroptosis in Hepatocellular Carcinoma Cell
por: Liyi Zou, et al.
Publicado: (2025)
por: Liyi Zou, et al.
Publicado: (2025)
ZMYM4 Acts as a Potential Prognostic Biomarker and Promotes the Malignant Progression of Hepatocellular Carcinoma Cells: It Is Regulated by miR‐34a‐5p
por: Qilin Yi, et al.
Publicado: (2025)
por: Qilin Yi, et al.
Publicado: (2025)
Hepatitis B Virus X Protein Contributes to Hepatocellular Carcinoma via Upregulation of KIAA1429 Methyltransferase and mRNA m6A Hypermethylation of HSPG2/Perlecan
por: Enakshi Sivasudhan, et al.
Publicado: (2024)
por: Enakshi Sivasudhan, et al.
Publicado: (2024)
TOP2A, Stabilized by IGF2BP3 in an m6A‐Dependent Manner, Drives Macrophage Recruitment and M2 Polarization in Hepatocellular Carcinoma by YAP1‐Mediated CCL2 Activation
por: Lu Li, et al.
Publicado: (2025)
por: Lu Li, et al.
Publicado: (2025)
SRPK1 Activation Facilitates Gli3S664 Phosphorylation and Promotes Metastasis in Esophageal Squamous Cell Carcinoma
por: Yongwei Ding, et al.
Publicado: (2025)
por: Yongwei Ding, et al.
Publicado: (2025)
LUCAT1 Mediates MYC‐Targeted Suppression of Squamous Cell Carcinoma
por: Yifan Wen, et al.
Publicado: (2026)
por: Yifan Wen, et al.
Publicado: (2026)
Expression of Concern: Amplification of Cyclinl1 in Uterine Cervical Carcinoma Has Prognostic Implications
Publicado: (2025)
Publicado: (2025)
Dysregulated BCL9 Controls Tumorigenicity and Ferroptosis Susceptibility by Binding With Nrf2 in Thyroid Carcinoma
por: Bin Wang, et al.
Publicado: (2024)
por: Bin Wang, et al.
Publicado: (2024)
P21‐Activated Kinase 1 (PAK1) Modulates Therapeutic Response to Ionizing Radiation in Head and Neck Squamous Cell Carcinoma Cells
por: Swetha Rajendran, et al.
Publicado: (2025)
por: Swetha Rajendran, et al.
Publicado: (2025)
CircDIAPH1 Promotes Liver Metastasis and Development of Colorectal Cancer by Initiation of CEACAM6 Expression
por: Wei Wang, et al.
Publicado: (2025)
por: Wei Wang, et al.
Publicado: (2025)
HORMAD1 Polymorphisms Influence Susceptibility to Esophageal Squamous Cell Carcinoma Through Gene–Smoking Interaction
por: Xinying Yue, et al.
Publicado: (2025)
por: Xinying Yue, et al.
Publicado: (2025)
Clinical and Genomic Phenotype of Brain Metastasis in Nasopharyngeal Carcinoma
por: Ying‐peng Peng, et al.
Publicado: (2024)
por: Ying‐peng Peng, et al.
Publicado: (2024)
Spatial Transcriptomic Landscape of Canine Oral Squamous Cell Carcinoma
por: Stephanie Goldschmidt, et al.
Publicado: (2025)
por: Stephanie Goldschmidt, et al.
Publicado: (2025)
The Transcription Factor ATF2 Accelerates Clear Cell Renal Cell Carcinoma Progression Through Activating the PLEKHO1/NUS1 Pathway
por: Zheng Lu, et al.
Publicado: (2025)
por: Zheng Lu, et al.
Publicado: (2025)
PTPN2 Expression in Hypopharyngeal Squamous Cell Carcinoma and Its Clinical Significance
por: Xue Li, et al.
Publicado: (2025)
por: Xue Li, et al.
Publicado: (2025)
GRPEL2 Modulates Apoptosis in Esophageal Squamous Cell Carcinoma via the JNK Signaling Pathway
por: Lu Wen, et al.
Publicado: (2025)
por: Lu Wen, et al.
Publicado: (2025)
miR‐150‐5p Regulates Merkel Cell Carcinoma Progression by Targeting FTO That Stabilizes CTNNB1 via m6A Modification
por: Bin Zheng, et al.
Publicado: (2025)
por: Bin Zheng, et al.
Publicado: (2025)
Targeting FGFR Attenuates Tumor Growth in an Anal Squamous Cell Carcinoma Patient Derived Xenograft Model
por: Thuc Ly, et al.
Publicado: (2025)
por: Thuc Ly, et al.
Publicado: (2025)
Identification of Interleukin‐Related Genes Signature for Prognosis Prediction in Head and Neck Squamous Cell Carcinoma Patients
por: Haojie Yang, et al.
Publicado: (2025)
por: Haojie Yang, et al.
Publicado: (2025)
β‐Elemene Inhibits Adrenocortical Carcinoma Cell Proliferation and Migration, and Induces Apoptosis by Up‐Regulating miR‐486‐3p/Targeting NPTX1 Axis
por: Yan Lin, et al.
Publicado: (2025)
por: Yan Lin, et al.
Publicado: (2025)
Tissue‐of‐origin for cancers determines HIF‐1 activation induced phenotypic heterogeneity
por: Shaofei Liu, et al.
Publicado: (2024)
por: Shaofei Liu, et al.
Publicado: (2024)
EXPRESSION OF CONCERN: Involvement of VILIP‐1 (Visinin‐Like Protein) and Opposite Roles of Cyclic AMP and GMP Signaling in In Vitro Cell Migration of Murine Skin Squamous Cell Carcinoma
Publicado: (2026)
Publicado: (2026)
EXPRESSION OF CONCERN: Combination Cisplatin and Sulforaphane Treatment Reduces Proliferation, Invasion, and Tumor Formation in Epidermal Squamous Cell Carcinoma
Publicado: (2024)
Publicado: (2024)
M2 Macrophage‐Derived Exosomal circ_0088494 Inhibits Ferroptosis via Promoting H3K4me1 Modification of STEAP3 in Cutaneous Squamous Cell Carcinoma
por: Jun Yin, et al.
Publicado: (2024)
por: Jun Yin, et al.
Publicado: (2024)
Expression of RIPK1 and FADD are associated with chemosensitivity and survival in head and heck squamous cell carcinoma via tanshinone IIA‐mediated modulation of the RIPK1‐FADD‐Caspase 8 complex
por: Bin Shen, et al.
Publicado: (2024)
por: Bin Shen, et al.
Publicado: (2024)
FGFR2 in the Development and Progression of Cutaneous Squamous Cell Cancer
por: Ethan M Kallenberger, et al.
Publicado: (2024)
por: Ethan M Kallenberger, et al.
Publicado: (2024)
EphA2/SHP2/SOX8 Axis: A Novel Target for Regulation of Migration and Cetuximab Treatment Sensitivity in Oral Squamous Cell Carcinoma
por: Dayong Yan, et al.
Publicado: (2026)
por: Dayong Yan, et al.
Publicado: (2026)
SSBP1 is a novel prognostic marker and promotes disease progression via p38MAPK signaling pathway in multiple myeloma
por: Pingping Xiao, et al.
Publicado: (2024)
por: Pingping Xiao, et al.
Publicado: (2024)
Ejemplares similares
-
DSN1 Interaction With Centromere‐Associated Proteins Promotes Chromosomal Instability in Hepatocellular Carcinoma
por: Hongrui Zhou, et al.
Publicado: (2024) -
Levels of Bile Acid Metabolism Are Associated With Alterations of Gut Microbes in Hepatocellular Carcinoma
por: Zhihao Yang, et al.
Publicado: (2024) -
CYP4F11, an NRF2 Target Gene, Promotes Hepatocellular Carcinoma Cell Growth
por: Jinjing Chen, et al.
Publicado: (2025) -
CAF Specific Expression of Podoplanin May Be Dispensable for the Malignancy of Malignant Melanoma
por: Saskia Tauch, et al.
Publicado: (2024) -
VPS45 Contributes to the Progression of Hepatocellular Carcinoma by Triggering the Wnt/β‐Catenin Signaling Pathway
por: Renhou Zhi, et al.
Publicado: (2025)